{"id":"362","presentation":"366 - Rates of Hospitalization Associated with the Use of Aldosterone Receptor Antagonists in Patients with Pulmonary Arterial Hypertension","session":"ORAL SESSION 37 - New Treatment Paradigms in Pulmonary Hypertension","filename":"366 - Rates of Hospitalization Associated with the Use of Aldosterone Receptor Antagonists in Patients with Pulmonary Arterial Hypertension.pdf","speaker":"M. Corkish<small>, Chapel Hill, NC, United States of America<\/small>","photo":"","cover":"https:\/\/s3.us-west-2.amazonaws.com\/us-cslide-prod-presentations\/ishlt2018\/362\/jpg\/366-ratesofhospitalizationassociatedwiththeuseofaldosteronereceptorantagonistsinpatientswithpulmonaryarterialhypertension\/thumbnails\/0.png","pdf":"\/file_access\/get_file\/E5947\/session_token\/8b381ce4f0f3c496e19395f290f7fc79","what":"pdf","code":"","priority":["html5","pdf","jpg","thumbnail"]}